http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2926135-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88534e7272a630633c9752d76a6a6f51
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70517
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
filingDate 2013-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24d185af9de308426b18b21671a603a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37729b6d22fabce1546bdb856a5a7901
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3843c75149b41b52b92048f8a3e0536a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_255b7c92dc26e47cc1944ac72c31b215
publicationDate 2015-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2926135-A1
titleOfInvention Method for determining compatibility between a donor and a recipient by means of the flow cytometric detection of alloreactive t cells
abstract The invention relates to a method for determining compatibility between a donor and a recipient by means of the flow cytometric detection of alloreactive T cells, comprising the following steps: a) adding a label to a blood sample taken from a donor/recipient pair to be analyzed, referred to as the labeled sample below, wherein the label is suitable for differentiation from a sample from the recipient; the other blood sample taken from the donor/recipient pair to be analyzed is referred to as the unlabeled sample below, b) thinning the two samples at least one time with a first medium, removing cellular constituents of the samples from the liquid phase, c) separately adding back the cellular constituents, in particular in the same volume of the blood sample remainder of the labeled sample and the blood sample remainder of the unlabeled sample, in a second medium, d) mixing a portion from the unlabeled sample and a portion of the labeled sample, in particular at a ratio of approximately 1:1, in order to obtain a mixture, e) stimulating antigen-presenting cells (APCs) in the mixture of labeled and unlabeled sample as per step d) of the claim by adding anti-CD28 or anti-CD28 and anti-CD49d antibodies followed by f) incubating the mixture for the first time for a duration of 1.5 h to 2.5 h, preferably 2 h, at a temperature of 35-39°C, preferably 37°C, optionally under a protective-gas atmosphere, CO2 atmosphere, g) adding a secretion inhibitor, h) mixing the sample from step d) of claim 1, i) followed by incubating for a second time for a duration of at least 2.5 h at a temperature of 35-39°C, preferably 37°C, optionally under a protective-gas atmosphere, CO2 atmosphere, j) optionally lysing erythrocytes, k) detecting lymphocytes by flow cytometry by means of the label and detecting CD4 or CD8 lymphocytes by flow cytometry, for example by means of labeled anti-CD4 and/or anti-CD8 antibodies, l) detecting lymphocytes activated by means of an intracellular cytokine and lymphocytes expressing an activation marker by flow cytometry, m) wherein alloreactivity between the individual from whom the labeled sample was taken and the individual from whom the unlabeled sample was taken is established if the following results occur in the flow cytometric detection: a. label pos/CD4 pos/DC69 pos/INFgamma pos, b. label neg/CD4 pos/CD69 pos/INFgamma pos, c. label pos/CD8 pos/CD69 pos/INFgamma pos, d. label neg/CD8 pos/CD69 pos/INFgamma pos.
priorityDate 2012-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6532927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518093
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP25094
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447827056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5048409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57472993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25199600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5289155
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP03319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226503519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226503520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9UGM3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73755215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428545465

Total number of triples: 45.